Showing results (971-980 of 1,797) with videos related to
Sort By:
Pageof 180
Mabs|October 4, 2012
Biodistribution studies with tumor-targeting bispecific antibodies reveal selective accumulation at the tumor siteThomas List, Dario NeriMabs|August 29, 2012
Progress in overcoming the chain association issue in bispecific heterodimeric IgG antibodiesChristian Klein, Claudio Sustmann, Markus Thomas, et al.Mabs|August 29, 2012
Tailored amino acid diversity for the evolution of antibody affinityAndrea González-Muñoz, Evert Bokma, Desmond O'Shea, et al.Mabs|August 23, 2012
Fourth World Antibody-Drug Conjugate Summit: February 29-March 1, 2012, Frankfurt, GermanyAlain Beck, John Lambert, Michael Sun, et al.Mabs|June 16, 2012
Marketing approval of mogamulizumab: a triumph for glyco-engineeringAlain Beck, Janice M ReichertMabs|June 16, 2012
Pharmacokinetics of engineered human monomeric and dimeric CH2 domainsKurt Gehlsen, Rui Gong, Dave Bramhill, et al.Mabs|February 5, 2014
Increasing FcγRIIa affinity of an FcγRIII-optimized anti-EGFR antibody restores neutrophil-mediated cytotoxicityStefanie Derer, Pia Glorius, Martin Schlaeth, et al.Mabs|February 5, 2014
Preclinical characterization of an anti-methamphetamine monoclonal antibody for human useMisty W Stevens, Rachel L Tawney, C Michael West, et al.Mabs|February 5, 2014
The ErbB2-targeting antibody trastuzumab and the small-molecule SRC inhibitor saracatinib synergistically inhibit ErbB2-overexpressing gastric cancerSiqi Han, Yanchun Meng, Qing Tong, et al.Mabs|February 5, 2014
Preclinical evaluation of 89Zr-labeled anti-CD44 monoclonal antibody RG7356 in mice and cynomolgus monkeys: Prelude to Phase 1 clinical studiesDanielle J Vugts, Derrek A Heuveling, Marijke Stigter-van Walsum, et al.Pageof 180